menu
    • menu

    Company profile for Imago BioSciences

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Our scientific efforts are aimed at developing drugs that improve the management of proliferative diseases of the bone marrow. Our clinical focus is on acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), polycythemia vera (PV), myelofibrosis (MF) and essential thrombocythemia (ET) – diseases sharing several features. These diseases are caused by acquired mutations in blood stem cells. These mutations drive excessiv...
    Our scientific efforts are aimed at developing drugs that improve the management of proliferative diseases of the bone marrow. Our clinical focus is on acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), polycythemia vera (PV), myelofibrosis (MF) and essential thrombocythemia (ET) – diseases sharing several features. These diseases are caused by acquired mutations in blood stem cells. These mutations drive excessive growth and alter the function of specific bone marrow cells. In the case of myelofibrosis, mutant megakaryocytes, the cells that make platelets, are a central cell type driving disease.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Imago BioSciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    329 Oyster Point Blvd. 3rd Floor South San Francisco, CA 94080
    Telephone
    Telephone
    415-529-5055
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://imagobio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/imago-biosciences-inc/?trk=companies_directory
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/imagobiorx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Merck Completes Tender Offer to Acquire Imago BioSciences, Inc.
    Merck Completes Tender Offer to Acquire Imago BioSciences, Inc.

    11 Jan 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230111005341/en

    BUSINESSWIRE
    11 Jan 2023
    Share Share
    Imago doses first subject in Phase II myelofibrosis treatment trial
    Imago doses first subject in Phase II myelofibrosis treatment trial

    22 Dec 2022

    // CLINICALTRIALSARENA

    https://www.clinicaltrialsarena.com/news/imago-myelofibrosis-treatment-trial/

    CLINICALTRIALSARENA
    22 Dec 2022
    Share Share
    Imago Announces First Participant Dosed Ph 2 Study of Bomedemstat
    Imago Announces First Participant Dosed Ph 2 Study of Bomedemstat

    20 Dec 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/12/20/2577487/0/en/Imago-BioSciences-Announces-First-Participant-Dosed-in-Investigator-Sponsored-Phase-2-Study-of-Bomedemstat-in-Combination-with-Ruxolitinib-in-Myelofibrosis.html

    GLOBENEWSWIRE
    20 Dec 2022
    Share Share
    Imago BioSciences Presents Positive Data from Ongoing Ph2 Study of Bomedemstat
    Imago BioSciences Presents Positive Data from Ongoing Ph2 Study of Bomedemstat

    12 Dec 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2022/12/12/2572137/0/en/Imago-BioSciences-Presents-Positive-Data-from-Ongoing-Phase-2-Study-of-Bomedemstat-in-Essential-Thrombocythemia-at-ASH-2022.html

    GLOBENEWSWIRE
    12 Dec 2022
    Share Share
    Imago BioSciences Presents Positive Data from Ongoing Ph2 Study of Bomedemstat
    Imago BioSciences Presents Positive Data from Ongoing Ph2 Study of Bomedemstat

    12 Dec 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2022/12/12/2572039/0/en/Imago-BioSciences-Presents-Positive-Data-from-Ongoing-Phase-2-Study-of-Bomedemstat-in-Advanced-Myelofibrosis-at-ASH-2022.html

    GLOBENEWSWIRE
    12 Dec 2022
    Share Share
    Merck begins Tender Offer to acquire Imago BioSciences
    Merck begins Tender Offer to acquire Imago BioSciences

    12 Dec 2022

    // INDIANPHARMAPOST

    https://www.indianpharmapost.com/news/merck-begins-tender-offer-to-acquire-imago-biosciences-13432

    INDIANPHARMAPOST
    12 Dec 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search